Full metadata record
DC FieldValueLanguage
dc.contributor.authorLin, Chih-Shengen_US
dc.contributor.authorKuo, Chao-Linen_US
dc.contributor.authorWang, Jui-Pingen_US
dc.contributor.authorCheng, Ju-Sangen_US
dc.contributor.authorHuang, Zheng-Wenen_US
dc.contributor.authorChen, Chi-Feien_US
dc.date.accessioned2014-12-08T15:13:39Z-
dc.date.available2014-12-08T15:13:39Z-
dc.date.issued2007-07-25en_US
dc.identifier.issn0378-8741en_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.jep.2007.05.008en_US
dc.identifier.urihttp://hdl.handle.net/11536/10548-
dc.description.abstractPerilla frutescens (L.) Britt. (Lamiaceae) has traditionally been used to treat diseases, including tumors, but the antitumorigenesis mechanism is unclear. We evaluated the effects of Perilla frutescens leaf extract (PLE) on proliferation and apoptosis inducing in human hepatoma HepG2 cells using a cell proliferation assay, flow cytometry, and cDNA microarrays. Gene expression and apoptosis were also assessed in HepG2 cells treated with a major constituent of PLE. rosmarinic acid (RosA). In the PLE-treated HepG2 cells, antiproliferative activity (105 mu g/mL) were observed, flow cytometry revealed significant apoptosis, and microarray data indicated that the expression of a lot apoptosis-related genes were regulated in a time-dependent manner. Compared with PLE, RosA (10 mu g/mL; a dose equivalent to 105 mu g/mL of PLE) was less effective in increasing the expression of apoptosis-related genes and apoptosis inducing in HepG2 cells. Thus, additional PLE constituents may influence apoptosis in HepG2 cells. The results of our study suggest that the PLE should be further investigated as a promising to treat hepatocellular carcinoma. (c) 2007 Elsevier Ireland Ltd. All rights reserved.en_US
dc.language.isoen_USen_US
dc.subjectPerilla frutescensen_US
dc.subjectrosmarinic aciden_US
dc.subjectcDNA microarrayen_US
dc.subjectapoptosisen_US
dc.subjecthepatocellular carcinomaen_US
dc.titleGrowth inhibitory and apoptosis inducing effect of Perilla frutescens extract on human hepatoma HepG2 cellsen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.jep.2007.05.008en_US
dc.identifier.journalJOURNAL OF ETHNOPHARMACOLOGYen_US
dc.citation.volume112en_US
dc.citation.issue3en_US
dc.citation.spage557en_US
dc.citation.epage567en_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.identifier.wosnumberWOS:000248467200020-
dc.citation.woscount20-
Appears in Collections:Articles


Files in This Item:

  1. 000248467200020.pdf

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.